Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?
Inman
M
M
D000818:Animals; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D051379:Mice; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D018927:Anti-Asthmatic Agents